INBX NASDAQ
Inhibrx Biosciences Inc.
1W: -2.6%
1M: -22.4%
3M: -0.1%
YTD: +29.2%
1Y: +185.4%
$96.99
-0.94 (-0.96%)
Weekly Expected Move ±7.5%
$82
$90
$97
$104
$112
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-05-30
Earliest Filing
2024-05-30
Latest Filing
partner: 1
investor: 1
Counterparties (Filed by INBX)
2 relationshipsCompanies named in INBX's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-28 | Regulation FD; Exhibits | View | |
| 2026-09-08 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-07-16 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-06-15 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-03 | Shareholder Vote | View | |
| 2026-04-21 | Regulation FD; Other Events; Exhibits | View | |
| 2026-02-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-16 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-23 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-28 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-01 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-03-17 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-21 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-01-13 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2024-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-04 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR